EXCL – Expect Solid Performance in 2021
EXCL’s revenue grew 3.5% throughout 2020. However, the jump in depreciation and financial expenses resulted in EXCL’s
SIDO – Satisfactory 4Q20 Result
SIDO is our top pick in the healthcare sector given its resilience performance amid the unfavorable economic condition,
UNVR – Limited Room to Grow
Our rating is on the back of an expected pressure on F&R and HPC segment to do quick turnaround amid uncertain
BBNI – Amid Low Credit Growth and Cost of Funds
BBNI's profit fell by -78.7% to IDR 3.28 trillion in 2020. Loan Loss Provisions rose sharply to IDR 22.59 Trillion (vs
PGAS – Top & Bottom Line Recovers in 3Q20
Performance recovery in 3Q20 allowed revenue to grow 14.5% QoQ to USD61.9 million. Gas distribution led the increase
INDF – Solid Growth Outlook
INDF experienced relatively modest performance of sales and net foreign exchange loss during the quarter. Nonetheless,
ICBP – Hoping for Better Performance
In 3Q20, ICBP recorded soft performance due to weak purchasing power in domestic market. Meanwhile, ICBP earning had
PTBA – Modest Performance Affected by Coal Prices
In 3Q20, PTBA managed to book a net profit of IDR439 billion or equal to +14% QoQ although on year-on-year period, it is
ISAT – Waiting for Merger Realization
The cellular segment was one of the segments that recorded growth, while intense competition making the company's
